Cancer disease modifying antibody 010207-01 produced by hybridoma cell line AR51A630.3.

Details for Australian Patent Application No. 2008232260 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Hahn, Susan E.; Young, David S.F.; Findlay, Helen P.; Cechetto, Lisa M.

Agent Davies Collison Cave

Pub. Number AU-A-2008232260

PCT Pub. Number WO2008/116299

Priority 60/908,042 26.03.07 US

Filing date 25 March 2008

Wipo publication date 2 October 2008

International Classifications

C12N 5/18 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Murine cells, e.g. mouse cells

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 (2006.01) Hybrid peptides

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

Event Publications

17 September 2009 PCT application entered the National Phase

  PCT publication WO2008/116299 Priority application(s): WO2008/116299

5 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008232262-Fluorinated derivatives of deferiprone

2008232254-Multivalent heterobifunctional polymers and methods of their use